You have requested access to member-only content.

CMS to bring site-neutral payment cuts for 340B drugs and clinic visits in certain settings

In the 2019 OPPS final rule, released November 2, CMS implemented several site-neutral payment policies, though the agency did delay or shelve other proposals due to stakeholder feedback.

This is an excerpt from member-only content. Please log in or become a member.

Not a member? Join now!

Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.

For questions and support, please call customer service: 800-650-6787.